Today’s top gainers include the company Mylan N.V. (NASDAQ:MYL) which is in the industry Drugs – Generic, gaining 0.88% today. In the last week its performance is 2.51%, and -3.52% for the past quarter. Currently, Mylan N.V., MYL has a target price of 58.13, so today’s gain of 0.88% is a significant step towards its target price. The GAP today is therefore -0.02%.
Mylan N.V. (NASDAQ:MYL), has a market cap of 23821.93, and is based in USA. Insider ownership is at 0.70%, and institutional ownership is 71.10%.
At the current price of 47, it has a dividend yield of *TBA, and its target price is 58.13. This is with a profit margin of 8.30%, and total debt/equity of 0.73. Mylan N.V. (NASDAQ:MYL) has a P/E of 29.79, as well as a forward P/E of 8.
With a current EPS of 1.56, and a forecasted EPS growth for next year at 17.82%,Mylan N.V. (NASDAQ:MYL) has had a EPS growth for the past five years at 20.20%. For the next five years EPS growth is projected to be 13.98%.
Performance for the year is -30.00%. Since its IPO date on 12/18/1987, the total performance to date is -13.83%.
Volume today for Mylan N.V. (NASDAQ:MYL), is 1445020, while its average volume is 5005.25. Whilst the total gain today was 0.88%, it did have a day high of -1.45%.
Volatility for this week has been at 2.83%, and 2.50% for the month. The 52-week low for Mylan N.V., MYL has been 25.03%, while the 52-week-high has reached -30.92%.
Looking at its return of investments, which is 8.20%, and its return on assets is 3.60%. Mylan N.V. (NASDAQ:MYL) has an operating margin of 14.60%. With a sales growth of 17.10% quarter over quarter. Bearing in mind that Mylan N.V., MYL is in the sector Healthcare, its long-term debt/equity is 0.62, and has a current ratio of 1.7 and 1.1 for quick ratio.
So what is the value of Mylan N.V.? Well its PEG is 2.13, and the P/S is 2.44, along with a P/B of 2.22. Meanwhile it has a p/cash of 19.86.